St. Jude Medical Inc (STJ.N)

STJ.N on New York Stock Exchange

1:31am IST
Change (% chg)

$0.17 (+0.21%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for STJ.N


St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement... (more)


Beta: 1.26
Market Cap(Mil.): $23,313.59
Shares Outstanding(Mil.): 284.28
Dividend: 0.31
Yield (%): 1.51


UPDATE 3-Abbott sales beat on higher demand for medical devices

* Shares up 2.3 pct (Adds details about St. Jude, Alere acquisitions and share move)

20 Jul 2016

BRIEF-St Jude Medical reports Q2 earnings per share $0.83

* Total crm sales were $395 million for q2 of 2016, an 8 percent decline compared with Q2 of 2015

20 Jul 2016

BRIEF-St Jude and Abbott Labs receive request for additional information from U.S. FTC

* Abbott labs, st. Jude medical each received request for additional information from u.s. Ftc relating to abbott's potential acquisition of st. Jude medical

13 Jul 2016

BRIEF-St. Jude Medical receives FDA approval of SyncAV CRT software

* FDA approval and launch of SyncAV CRT software, designed to build upon company's first-to-market multipoint pacing technology Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

11 Jul 2016

St Jude in $39.25 mln shareholder settlement over heart devices

July 8 St. Jude Medical Inc has reached a $39.25 million class action settlement with shareholders to resolve claims it downplayed the possible dangers associated with a product used to connect implantable defibrillators to patients' hearts.

08 Jul 2016

BRIEF-St Jude Medical announces European launch of latest in pressurewire guidewire technology

* Announces European launch of latest in PressureWire Guidewire technology to measure pressure differences across narrowed coronary arteries

18 May 2016

U.S. RESEARCH ROUNDUP-Aflac, St. Jude Medical, Gap

May 10 Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Your Community Bankshares, Kohls and Nordic American Tanker, on Tuesday. HIGHLIGHTS * Aflac Inc : FBR cuts to market perform rating * Sprouts Farmers market Inc : Goldman Sachs cuts to sell from neutral * Hasbro Inc : Piper Jaffray cuts to neutral from overweight * St. Jude Medical Inc : SunTrust

10 May 2016

BRIEF-st. Jude medical sets quarterly dividend of $0.31per share

* Sets quarterly dividend of $0.31per share Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

04 May 2016

Abbott deal for St. Jude spurs company split talk

NEW YORK When Abbott Laboratories said on Thursday it would buy heart device company St. Jude Medical Inc for $25 billion, it set off a flurry of Wall Street speculation over whether Abbott Chief Executive Miles White is laying groundwork to split the company yet again.

29 Apr 2016

Earnings vs. Estimates